BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 17117082)

  • 1. Gallbladder metastasis from malignant melanoma: diagnosis with FDG PET/CT.
    Rehani B; Strohmeyer P; Jacobs M; Mantil J
    Clin Nucl Med; 2006 Dec; 31(12):812-3. PubMed ID: 17117082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma.
    Falk MS; Truitt AK; Coakley FV; Kashani-Sabet M; Hawkins RA; Franc B
    Nucl Med Commun; 2007 Apr; 28(4):273-80. PubMed ID: 17325590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic infarction mimicking a necrotizing metastasis of malignant melanoma on F-18 FDG PET/CT.
    Ahmadzadehfar H; Brockmann H; Schmiedel A; Biersack HJ; Ezziddin S
    Clin Nucl Med; 2008 Aug; 33(8):571-2. PubMed ID: 18645383
    [No Abstract]   [Full Text] [Related]  

  • 4. FDG PET/CT demonstrates the effectiveness of isolated limb infusion for malignant melanoma.
    Ryan ER; Hill AD; Skehan SJ
    Clin Nucl Med; 2006 Nov; 31(11):707-8. PubMed ID: 17053391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoplastic melanoma: true positive and false negative findings on F-18 FDG-PET/CT.
    Roarke MC; Nguyen BD; Pockaj BA
    Clin Nucl Med; 2008 Aug; 33(8):562-4. PubMed ID: 18645380
    [No Abstract]   [Full Text] [Related]  

  • 6. Can (18)F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma?
    Kang S; Ahn BC; Hong CM; Song BI; Lee HJ; Jeong SY; Lee SW; Lee J; Lee SJ
    Nuklearmedizin; 2011; 50(3):116-21. PubMed ID: 21246162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ
    J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
    Freudenberg LS; Schueler AO; Beyer T; Antoch G; Kühl H; Bornfeld N; Bockisch A; Egelhof T
    Surv Ophthalmol; 2004; 49(5):537-40. PubMed ID: 15325198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique presentation of appendicitis: F-18 FDG PET/CT.
    Koff SG; Sterbis JR; Davison JM; Montilla-Soler JL
    Clin Nucl Med; 2006 Nov; 31(11):704-6. PubMed ID: 17053390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A; Kalinyak JE; McDougall IR
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography-computerized tomography findings in a urinary bladder paraganglioma.
    Thambugala GM; Fulham MJ; Mohamed A
    Australas Radiol; 2007 Oct; 51 Spec No.():B45-7. PubMed ID: 17875156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased F-18 FDG uptake on positron emission tomography/computed tomography imaging caused by plantar fibromatosis.
    Scheler J; Rehani B; Percy T; Pelstring R; Bharija A; Ames D; Mantil J
    Clin Nucl Med; 2008 Apr; 33(4):280-1. PubMed ID: 18356670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B
    J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET/CT flip flop phenomenon in treated lymphoma of bone.
    Lin EC
    Clin Nucl Med; 2006 Dec; 31(12):803-5. PubMed ID: 17117078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of malignant melanoma with cardiac and gallbladder metastases detected by FDG PET-CT.
    Ozülker T; Ozülker F; Cicin I; Ozpaçac T
    Clin Nucl Med; 2009 Dec; 34(12):948-9. PubMed ID: 20139846
    [No Abstract]   [Full Text] [Related]  

  • 19. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
    Sato M; Okumura T; Kaito K; Kiyoshima M; Asato Y; Uchiumi K; Iijima H; Hashimoto I; Kaburagi T; Amemiya R
    Ann Nucl Med; 2009 Jan; 23(1):49-57. PubMed ID: 19205838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fever of unknown origin: the role of 18F-FDG PET/CT.
    Keidar Z; Gurman-Balbir A; Gaitini D; Israel O
    J Nucl Med; 2008 Dec; 49(12):1980-5. PubMed ID: 18997040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.